Biofrontera Inc. (BFRI) Misses Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Biofrontera (BFRI) PT Lowered to $16 at Roth/MKM
August 15, 2024 1:44 PM EDTRoth/MKM analyst Jonathan Aschoff lowered the price target on Biofrontera (NASDAQ: BFRI) to $16.00 (from $25.00) while maintaining a Buy rating.
The analyst comments "BFRI ended 2Q24 with cash of $4.4M, enough to fund operations into early 2025. 2Q24 sales were $7.8M and we still... More
